DK1174131T3 - Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom - Google Patents

Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom

Info

Publication number
DK1174131T3
DK1174131T3 DK01117308T DK01117308T DK1174131T3 DK 1174131 T3 DK1174131 T3 DK 1174131T3 DK 01117308 T DK01117308 T DK 01117308T DK 01117308 T DK01117308 T DK 01117308T DK 1174131 T3 DK1174131 T3 DK 1174131T3
Authority
DK
Denmark
Prior art keywords
parkinson
agent
disease
treatment
improve
Prior art date
Application number
DK01117308T
Other languages
English (en)
Inventor
Yasuto Itoyama
Hiroyuki Kato
Tsutomu Araki
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK1174131T3 publication Critical patent/DK1174131T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
DK01117308T 2000-07-18 2001-07-17 Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom DK1174131T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000216763 2000-07-18

Publications (1)

Publication Number Publication Date
DK1174131T3 true DK1174131T3 (da) 2007-02-05

Family

ID=18711968

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01117308T DK1174131T3 (da) 2000-07-18 2001-07-17 Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom

Country Status (19)

Country Link
US (2) US7019032B2 (da)
EP (1) EP1174131B1 (da)
KR (1) KR100759771B1 (da)
CN (1) CN1179722C (da)
AT (1) ATE341318T1 (da)
AU (1) AU780328B2 (da)
BR (1) BR0102940A (da)
CA (1) CA2353205C (da)
DE (1) DE60123528T2 (da)
DK (1) DK1174131T3 (da)
ES (1) ES2272383T3 (da)
HU (1) HUP0102987A3 (da)
MX (1) MXPA01007210A (da)
NO (1) NO20013544L (da)
NZ (1) NZ513040A (da)
PT (1) PT1174131E (da)
RU (1) RU2275906C2 (da)
TW (1) TWI290831B (da)
ZA (1) ZA200105886B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제
US7928143B2 (en) 2003-10-03 2011-04-19 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
WO2005032537A1 (en) * 2003-10-03 2005-04-14 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
BRPI0415001A (pt) * 2003-10-03 2006-11-07 Ono Pharmaceutical Co droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo
US20070066686A1 (en) * 2003-10-03 2007-03-22 Ono Pharmaceutical Co., Ltd. Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient
JP4730303B2 (ja) 2004-04-28 2011-07-20 小野薬品工業株式会社 （２ｒ）−２−プロピルオクタン酸とアミンとからなる結晶
TW200613009A (en) * 2004-06-11 2006-05-01 Ono Pharmaceutical Co Capsule having chewing stability
EP1997486B1 (en) 2006-03-09 2012-05-16 Ono Pharmaceutical Co., Ltd. Therapeutic agent for functional brain disease
US20110112010A1 (en) * 2008-02-15 2011-05-12 The Government of the United States of America, as represented by The National Institutes of Health Octanoic acid formulations and methods of treatment using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209564B (en) 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
EP0632008B1 (en) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentanoic acid derivatives
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제

Also Published As

Publication number Publication date
ES2272383T3 (es) 2007-05-01
CA2353205A1 (en) 2002-01-18
EP1174131A1 (en) 2002-01-23
EP1174131B1 (en) 2006-10-04
ZA200105886B (en) 2002-01-17
TWI290831B (en) 2007-12-11
MXPA01007210A (es) 2004-10-29
NZ513040A (en) 2003-02-28
DE60123528D1 (de) 2006-11-16
AU5446401A (en) 2002-01-24
PT1174131E (pt) 2007-01-31
HU0102987D0 (en) 2001-09-28
BR0102940A (pt) 2002-03-05
US20060052453A1 (en) 2006-03-09
NO20013544L (no) 2002-01-21
NO20013544D0 (no) 2001-07-17
HUP0102987A3 (en) 2003-02-28
CN1179722C (zh) 2004-12-15
KR100759771B1 (ko) 2007-10-04
CN1334081A (zh) 2002-02-06
KR20020007188A (ko) 2002-01-26
DE60123528T2 (de) 2007-02-15
RU2275906C2 (ru) 2006-05-10
US7019032B2 (en) 2006-03-28
US20020032185A1 (en) 2002-03-14
HUP0102987A2 (hu) 2002-04-29
AU780328B2 (en) 2005-03-17
CA2353205C (en) 2008-10-07
ATE341318T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
FI950309A0 (fi) Proliiniamidijohdannaisia
GB0005251D0 (en) Therapeutic compounds
HK1084588A1 (en) Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DK0947513T3 (da) Tricykliske aminderivater
EA200201234A1 (ru) Производные сульфонамида
DE60104589D1 (de) Therapeutisches Mittel zur Behandlung von Dermatitis
ATE403644T1 (de) Amidinophenylbrenztraubensäure-derivat
SE0201662D0 (sv) Pharmaceutical combination
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
PT784973E (pt) Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
ATE382367T1 (de) Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern
ATE247963T1 (de) Medikament zur behandlung von glaukoma und ischämischer retinopathie
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
DK0706796T3 (da) Dopamingenoptagelsesinhibitorer til behandling af parkinsonisme
ATE158503T1 (de) Aids-virus-infektion hemmende zusammensetzung